“Opioid pain medication acts on a receptor in the brain called the ‘mu opioid receptor’. This receptor is involved in the way your body processes pain,” MacKay said. “Journavx works through a ...

Vertex Pharmaceuticals via AP The average time to meaningful pain relief ranged from two to four hours, compared to eight hours in the placebo group. Journavx works by inhibiting the NaV1.8 pain ...

Unlike opioids, which bind to brain receptors to reduce pain but often lead to dependence and addiction, Journavx works differently. The medication blocks specific proteins that trigger pain signals ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

Journavx was found to help reduce pain by blocking pain signals in the peripheral nervous system before pain signals reach the brain. Reshma Kewalramani, CEO and president of Vertex, called the ...

Seán Duke is the Science and Health Editor for Newsweek, based in Dublin, Ireland. He has 25 years of experience as a science journalist, and editor with The Irish Times, the Irish Independent ...

The medication blocks specific proteins that trigger pain signals before they reach the brain. “In trying to ... dunk in that it’s a very different pathway and mechanism of action.

The average time to meaningful pain relief ranged from two to four hours, compared to eight hours in the placebo group. Journavx works by inhibiting the NaV1.8 pain signal in the peripheral nervous ...

This challenge has forced medicine into ... or signal switches found in pain-sensing neurons. NaV1.8 plays a crucial role in transmitting pain signals from the body to the brain.